Abbott has entered a global partnership focusing on the integration of its advanced FreeStyle Libre continuous glucose ...

Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...

Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...

Medtronic reported 4.1% organic revenue growth and 6.2% adjusted EPS growth. See why we upgraded MDT stock to 'Buy' with a ...

Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination.

The company’s MiniMed insulin pump increased its customer base and strengthened its continuous glucose monitor (CGM) attachment rates, as per the earnings release. Medtronic has not changed its ...

with Medtronic offering $738 million for the business, saying it would combine EOFlow’s tubeless, wearable, and fully disposable EOPatch with its continuous glucose monitor (CGM) devices and ...

Amsterdam played host to this year's edition of the International Conference on Advanced Technologies & Treatments for ...

one is Abbott Laboratories with its FreeStyle Libre CGM and the other is Medtronic. DXCM being the market leader in the industry with ~ billion revenue coming from CGM sales, Abbott and Medtronic ...